Linear Health Sciences

13 articles about Linear Health Sciences

• Linear Health Sciences Publishes Whitepaper Examining IV Dislodgement

  3/27/2024

  Linear Health Sciences announced the publication of a new whitepaper on accidental dislodgement of IV catheter lines.

• Linear Health Sciences Awarded IV Therapy Products - Needleless Connectors Agreement with Premier, Inc.

  1/10/2024

  Linear Health Sciences has been awarded a national group purchasing agreement for the IV Therapy - Needleless Connectors category with Premier, Inc. Effective Jan. 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Orchid SRV force-activated separation device.

• Linear Health Sciences Announces Expanded Indication for Orchid Safety Release Valve

  10/17/2023

  Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™ safety release valve.

• Linear Health Sciences Advances Orchid SRV Commercialization With Two Key Hires

  6/27/2023

  Medical device company Linear Health Sciences today advanced the commercialization of its Orchid SRV ™ tension-activated breakaway safety release valve, announcing the appointment of Rob Headley as vice president of sales and business development, and Jessica Czamanski as director of product and regulatory affairs.

• Linear Health Sciences Announces Expanded Pediatric Indication for Orchid Safety Release Valve

  5/16/2023

  Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™, a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.

• Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device

  11/8/2022

  Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device.

• Linear Health Sciences Recognized for Leading the Way to Safer IV Treatment for Children

  10/12/2022

  Device Intended to Reduce Risk of IV Catheter Failure and Replacement in Hospitals Recognized by Pediatrics Consortium, FDA.

• CORRECTING and REPLACING Linear Health Sciences Announces U.S. FDA Clearance and Health Canada Approval of Its Orchid Safety Release Valve (SRV)

  5/17/2022

  Medical device company Linear Health Sciences has received U.S. FDA clearance and Health Canada approval of its Orchid SRV™, a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.

• Linear Health Sciences Announces U.S. FDA Clearance and Health Canada Approval of Its Orchid Safety Release Valve (SRV)

  5/17/2022

  Medical device company Linear Health Sciences has received U.S. FDA clearance and Health Canada approval of its Orchid SRV™ , a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.

• Linear Health Sciences Enters Exclusive Distribution Agreement with Alliance Medical for Orchid SRV

  11/29/2018

  Linear Health Sciences today announced that it has entered into an exclusive distribution agreement with Alliance Medical, a leading distributor for emerging medical technologies, for the Orchid Safety Release Valve™, a patient safety device designed to help prevent intravenous (IV) catheter dislodgement.

• Orchid SRV Featured Among Latest Innovations in Emergency Medicine

  10/9/2018

  Linear Health Sciences was chosen to exhibit its patented vascular access technology in a special area of the American College of Emergency Physicians (ACEP) scientific assembly, the world's largest emergency medicine conference.

• Linear Health Sciences Announces Issuance of First U.S. Patent

  1/24/2018

  Linear Health Sciences today announced that the United States Patent and Trademark Office has issued the company's first patent related to its flagship product, the Orchid Safety Release Valve.

• Linear Health Sciences Announces Additional Funding of $1.5M for Orchid Safety Release Valve

  12/12/2017

  Linear Health Sciences today announced additional investment funding of $1.538 million, bringing total company financing to nearly $3M.